Toxic epidermal necrolysis: current evidence, practical management and future directions (Q36222123)

12 August 2017

1 reference

title

Toxic epidermal necrolysis: current evidence, practical management and future directions (English)

1 reference

toxic epidermal necrolysis

12 August 2017

1 reference

Chave TA

1

1 reference

12 August 2017

Mortimer NJ

2

1 reference

12 August 2017

Sladden MJ

3

1 reference

12 August 2017

Hall AP

4

1 reference

12 August 2017

Hutchinson PE

5

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

British Journal of Dermatology

12 August 2017

1 reference

12 August 2017

153

1 reference

12 August 2017

2

1 reference

12 August 2017

241-253

1 reference

Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study

12 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Outcome of patients with toxic epidermal necrolysis syndrome revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

SCORTEN: a severity-of-illness score for toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

[Plasmapheresis and immunopathogenetic aspects of toxic epidermal necrolysis]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Gene expression levels of cytokine profile and cytotoxic markers in non-immediate reactions to drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Role of NF-kappaB in the apoptotic-resistant phenotype of keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Dexamethasone and tumor necrosis factor-alpha act together to induce the cellular inhibitor of apoptosis-2 gene and prevent apoptosis in a variety of cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Cytokine removal in septic patients with continuous venovenous hemofiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role of continuous veno-venous haemofiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Super high flux hemofiltration: a new technique for cytokine removal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

TNF-alpha elimination with high cut-off haemofilters: a feasible clinical modality for septic patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Plasmapheresis in toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Toxic epidermal necrolysis in a burns centre: a 6-year review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Preventing complications of central venous catheterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Amniotic membrane in the surgical management of acute toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Successful dexamethasone pulse therapy in a toxic epidermal necrolysis (TEN) patient featuring recurrent TEN to oxazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Suppression of apoptosis by glucocorticoids in glomerular endothelial cells: effects on proapoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Glucocorticoids reduce ischemia-reperfusion-induced myocardial apoptosis in immature hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Statin-induced apoptosis of vascular endothelial cells is blocked by dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Toxic epidermal necrolysis. A review of 75 cases in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Cyclosporin A-sensitive calcium signaling represses NFkappaB activation in human bronchial epithelial cells and enhances NFkappaB activation in Jurkat T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Restoration of mitochondrial function reverses developmental neuronal death in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Mechanism of azathioprine-induced injury to hepatocytes: roles of glutathione depletion and mitochondrial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Role of mitochondria in ciprofloxacin induced apoptosis in bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: our experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Toxic epidermal necrolysis: does immunoglobulin make a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Dermatologic side effects of thalidomide in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Thalidomide-induced toxic epidermal necrolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Akt regulates cell survival and apoptosis at a postmitochondrial level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Apoptosis induced by microtubule disrupting drugs in cultured human lymphoma cells. Inhibitory effects of phorbol ester and zinc sulphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Regulation of caspase activation and apoptosis by cellular zinc fluxes and zinc deprivation: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

T-lymphocyte subsets and interleukin-2 production in zinc-deficient rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Zinc chloride-mediated reduction of apoptosis as an adjunct immunosuppressive modality in cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Recombinant granulocyte colony-stimulating factor in the management of toxic epidermal necrolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-α

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06721.X

10.1111/J.1365-2133.2005.06721.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference